GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Cyclically Adjusted Revenue per Share

Abbott Laboratories (Pakistan) (KAR:ABOT) Cyclically Adjusted Revenue per Share : ₨412.40 (As of Mar. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s adjusted revenue per share for the three months ended in Mar. 2024 was ₨163.692. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₨412.40 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Abbott Laboratories (Pakistan)'s average Cyclically Adjusted Revenue Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-13), Abbott Laboratories (Pakistan)'s current stock price is ₨680.42. Abbott Laboratories (Pakistan)'s Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₨412.40. Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio of today is 1.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories (Pakistan) was 2.19. The lowest was 0.90. And the median was 1.21.


Abbott Laboratories (Pakistan) Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Cyclically Adjusted Revenue per Share Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 348.97 394.85

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 363.89 375.73 388.11 394.85 412.40

Competitive Comparison of Abbott Laboratories (Pakistan)'s Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio falls into.



Abbott Laboratories (Pakistan) Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories (Pakistan)'s adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=163.692/131.7762*131.7762
=163.692

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories (Pakistan) Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 49.911 100.560 65.405
201409 48.114 100.428 63.133
201412 57.715 99.070 76.769
201503 43.615 99.621 57.693
201506 56.534 100.684 73.992
201509 55.897 100.392 73.372
201512 60.271 99.792 79.588
201603 49.911 100.470 65.463
201606 62.087 101.688 80.458
201609 59.460 101.861 76.923
201612 67.375 101.863 87.161
201703 55.112 102.862 70.604
201706 68.053 103.349 86.772
201709 67.457 104.136 85.362
201712 75.848 104.011 96.095
201803 64.731 105.290 81.015
201806 76.016 106.317 94.219
201809 79.797 106.507 98.729
201812 83.026 105.998 103.218
201903 73.772 107.251 90.642
201906 82.808 108.070 100.973
201909 71.115 108.329 86.507
201912 80.383 108.420 97.699
202003 82.342 108.902 99.638
202006 86.571 108.767 104.884
202009 86.229 109.815 103.473
202012 105.337 109.897 126.309
202103 101.000 111.754 119.095
202106 111.414 114.631 128.078
202109 125.372 115.734 142.750
202112 113.629 117.630 127.295
202203 120.261 121.301 130.646
202206 131.675 125.017 138.794
202209 125.372 125.227 131.929
202212 125.701 125.222 132.280
202303 140.877 127.348 145.776
202306 137.421 128.729 140.674
202309 146.715 129.860 148.880
202312 145.395 129.419 148.043
202403 163.692 131.776 163.692

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Abbott Laboratories (Pakistan)  (KAR:ABOT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=680.42/412.4
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories (Pakistan) was 2.19. The lowest was 0.90. And the median was 1.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Abbott Laboratories (Pakistan) Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines